Diagnostic and therapeutic significance of the oxidative stress parameters in children

Journal of Medical Biochemistry

Volumn 29, Issue 3, 2010, Pages 196-203

  Bajčetić, Milica ^a,b   Brajović, Milan ^c   Korkut Tešić, Radojka ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^c Clinical Centre Zvezdara   (Serbia)

^d Children's Hospital Korkut Te i   (Serbia)

Author keywords

antioxidants; children; oxidative stress parameters

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; ACROLEIN; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CARVEDILOL; CATALASE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORESCENT DYE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; ISOPROSTANE; MELATONIN; METHYLGLYOXAL; NITRITE; PENTOSIDINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; TOCOPHEROL; UBIQUINONE; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; CHILD; CHILDHOOD DISEASE; COLORECTAL ADENOMA; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; HEMOCHROMATOSIS; HUMAN; KWASHIORKOR; LABORATORY TEST; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARAMETER; REVIEW;

EID: 77955258802     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0019-6     Document Type: Review

References (124)

1. Bajčetić M, Jelisavčić M, Mitrović J, Divac N, Simeunović S, Samardžić R, Gorodischer R. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol 2005; 61: 775-779
2. Bajčetić M, Divac N, Samardžić R. Nova iskustva sa nezeljenim dejstvima kardiovaskularnih lekova u pedijatrijskoj praksi. U: Nova iskustva sa nezeljenim dejstvima lekova. Urednik: Slobodan M. Jankovic. 2002: 72-84.
3. Bajčetić M. Primena lekova van i bez upotrebne licence u neonatologiji i pedijatriji. U: Klinicki seminari 2007; 2008: 128-135
4. Tsukahara H, Ohta N, Sato S, Hiraoka M, Shukunami K, Uchiyama M, et al. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood. Free Radic Res 2004; 38: 691-695
5. Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, Endo F. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res 2002; 36: 189-193
6. Shimizu T, Satoh Y, Syoji H , Tadokoro R, Sinohara K, Oguchi S, et al. Effects of parenteral lipid infusion on DNA damage in very low birth weight infants. Free Radic Res 2002; 36: 1067-1070
7. Saugstad OD. Oxidative stress in the newborn - a 30- year perspective. Biol Neonate 2005; 88: 228-236
8. Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31: 343-349
9. Buonocore G, Perrone S, Longini M, Paffetti P Vezzosi P Gatti MG, Bracci R. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003; 126: 1224-1230
10. Tsukahara H, Jiang MZ, Ohta N, Sato S, Tamura S, Hiraoka M, et al. Oxidative stress in neonates: evaluation using specific biomarkers. Life Sci 2004; 75: 933-938
11. Tsukahara H, Sugaya T, Hayakawa K, Mori Y, Hiraoka M, Hata A, Mayumi M. Quantification of L-type fatty acid binding protein in the urine of preterm neonates. Early Hum Dev 2005; 81: 643-646
12. Tsukahara H, Toyo-Oka M, Kanaya Y, Ogura K, Kawatani M, Hata A, et al. Quantitation of glutathione S transferase-pi in the urine of preterm neonates. Pediatr Int 2005; 47: 528-531 (Pubitemid 41806162)
13. Bajčetić M, Ilić M, Majkić-Singh N, Novaković I, Vukotić M, Nedeljković S, Simeunović S. Cardiovascular risk factors and blood pressure in a primary care unit: Yugoslav Study of the Precursors of Atherosclerosis in School Children (YUSAD). Exp Clin Cardiol 2006; 11: 89-93.
14. Turi S, Friedman A, Bereczki C, Papp F Kovacs J, Karg E, Nemeth I. Oxidative stress in juvenile essential hypertension. J Hypertens 2003; 21: 145-152
15. Bajčetić M, Kokić-Nikolić A, Dukić M, Košutić J, Mitrović J, Mijalković D, Jovanović I, Simeunović S, Spasić MB, Samardž ić R. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12- month, two-center, open-label study. Clinical Therapeutics 2008; 30: 702-714
16. Lull ME, Carkaci-Salli N, Freeman WM, Myers JL, Midgley FM, Thomas NJ, Kimatian SJ, Vrana KE, Undar A. Plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass. Pediatr Res 2008; 63: 638-644
17. Lim DS, Mooradian SJ, Goldberg CS, Gomez C, Crowley DC, Rocchini AP Charpie JR. Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am J Cardiol 2004; 94: 828-831
18. Takeuchi M, Takahashi T, Taga N, Iwasaki T, Ohe K, Shimizu H, et al. Right ventricle of patients undergoing congenital cardiac surgery differentially expresses haem oxygenase-1 and heat shock protein 70 genes. J Int Med Res 2003; 31: 413-417
19. Stringer DM, Sellers EA, Burr LL, Taylor CG. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus. Pediatr Diabetes 2009; 10: 269-277
20. Tsukahara H, Sekine K, Uchiyama M, Kawakami H, Hata I, Todoroki Y, et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003; 54: 419-424
21. Chiarelli F, Di Marzio D, Santilli F, Mohn A, Blasetti A, Cipollone F, et al. Effects of irbesartan on intracellular antioxidant enzyme expression and activity in ado I escents and young adults with early diabetic angiopathy. Diabetes Care 2005; 28: 1690-1697
22. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Estimation of lipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants. Free Radic Res 2005; 39: 933-942
23. Hata I, Kaji M, Hirano S, Shigematsu Y, Tsukahara H, Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int 2006; 48: 58-61.
24. Ristoff E, Hebert C, Njalsson R, Norgren S, Rooya- ckers O, Larsson A. Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione? J Inherit Metab Dis 2002; 25: 577-584
25. Menke T, Niklowitz P, Reinehr T, De Sousa GJ, Andler W. Plasma levels of coenzyme Q10 in children with hyperthyroidism. Horm Res 2004; 61: 153-158 (Pubitemid 38437683)
26. Giray B, Hincal F. Oxidative DNA base damage, antioxidant enzyme activities and selenium status in highly iodine-deficient goitrous children. Free Radic Res 2002; 36: 55-62.
27. Patel MN. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic Res 2002; 36: 1139-1146
28. Hargreaves IP Sheena Y, Land JM, Heales SJ. Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment. J Inherit Metab Dis 2005; 28: 81-88
29. Molnar D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 2004; 28: 1197-1202
30. Sirtori LR, Dutra-Filho CS, Fitarelli D, Sitta A, Haeser A, Barschak AG, et al. Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 2005; 1740: 68-73.
31. Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adreno- leukodystrophy. Biochim Biophys Acta 2004; 1688: 26-32.
32. Medina J, Garcia-Buey L, Moreno-Otero R. Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther 2003; 17: 1-16.
33. Zhou JF, Lou JG, Zhou SL, Wang JY. Potential oxidative stress in children with chronic constipation. World J Gastroenterol 2005; 11: 368-371
34. Cabre E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2003; 6: 569-576
35. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004; 8: 549-558
36. Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, et al. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr 2005; 147: 62-66
37. Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 2001; 34: 587-592
38. Muller T, Langner C, Fuchsbichler A, Heinz-Erian P Ellemunter H, Schlenck B, et al. Immunohisto- chemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 2004; 39: 963-969
39. Misaki K, Takitani K, Ogihara T, Inoue A, Kawakami C, Kuno T, et al. Alpha-tocopherol content and alpha- tocopherol transfer protein expression in leukocytes of children with acute leukemia. Free Radic Res 2003; 37: 1037-1042
40. Caron JE, Krull KR, Hockenberry M, Jain N, Kaemingk K, Moore IM. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2009; 53: 551-556
41. Ghosh S, Bandyopadhyay S, Bhattacharya DK, Mandal C. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia. Ann Hematol 2005; 84: 76-84.
42. Kassab-Chekir A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, Amri F, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003; 338: 79-86.
43. Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. J Clin Gastroenterol 2005; 39: (4 Suppl 2), S167-175. (Pubitemid 40397032)
44. Pagano G, Degan P D'Ischia M, Kelly FJ, Pallardo FV, Zatterale A, et al. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients. Carcinogenesis 2004; 25: 1899-1909
45. Somjee SS, Warrier RP Thomson JL, Ory-Ascani J, Hempe JM. Advanced glycation end-products in sickle cell anaemia. Br J Haematol 2005; 128: 112-118
46. Gurkan F, Atamer Y, Ece A, Kocyigit Y, Tuzun H, Mete M. Relationship among serum selenium levels, lipid peroxidation, and acute bronchiolitis in infancy. Biol Trace Elem Res 2004; 100: 97-104.
47. Yachie A, Toma T, Mizuno K, Okamoto H, Shimura S, Ohta K, et al. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children. Exp Biol Med (Maywood) 2003; 228: 550-556
48. Cemek M, Dede S, Bayiroglu F Caksen H, Cemek F Yuca K. Oxidant and antioxidant levels in children with acute otitis media and tonsillitis: a comparative study. Int J Pediatr Otorhinolaryngol 2005; 69: 823-827
49. Gangemi S, Saija A, Minciullo PL, Tomaino A, Cimino F Bisignano G, et al. Serum levels of malondialdehyde and 4-hydroxy-2,3-nonenal in patients affected by familial chronic nail candidiasis. Inflamm Res 2004; 53: 601-603
50. Yilmaz T, Kocan EG, Besler HT, Yilmaz G, Gursel B. The role of oxidants and antioxidants in otitis media with effusion in children. Otolaryngol Head Neck Surg 2004; 131: 797-803. (Pubitemid 39575931)
51. Kaygusuz I, Ilhan N, Karlidag T, Keles E, Yalcin S, Cetiner H. Free radicals and scavenging enzymes in chronic tonsillitis. Otolaryngol Head Neck Surg 2003; 129: 265-268
52. Yilmaz T, Kocan EG, Besler HT. The role of oxidants and antioxidants in chronic tonsillitis and adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol 2004; 68:1053-1058 (Pubitemid 38986919)
53. Serarslan G, Yilmaz HR, Sogut S. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis. Clin Exp Dermatol 2005; 30: 267-271
54. Jareno EJ, Roma J, Romero B, Marin N, Muriach M, Johnsen S, et al. Serum malondialdehyde correlates with therapeutic efficiency of high activity antiret to- viral therapies (HAART) in HIV-1 infected children. FreeRadic Res 2002; 36: 341-344
55. Stephensen CB, Marquis GS, Douglas SD, Wilson CM. Plasma cytokines and oxidative damage in HIV- positive and HIV-negative adolescents and young adults: a protective role for IL-10? Free Radic Res 2005; 39: 859-864
56. Hayashi M, Arai N, Satoh J, Suzuki H, Katayama K, Tamagawa K, Morimatsu Y. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol 2002; 17: 725-730
57. Tsukahara H, Haruta T, Ono N, Kobata R, Fukumoto Y, Hiraoka M, Mayumi M. Oxidative stress in childhood meningitis: measurement of 8-hydroxy-2'- deoxyguanosine concentration in cerebrospinal fluid. Redox Rep 2000; 5: 295-298
58. Mirić D, Katanić R, Kisić B, Zorić L, Mirić B, Mitić R, Dragojević I. Oxidative stress and myeloperoxidase activity during bacterial meningitis: effects of febrile episodes and the BBB permeability. Clin Biochem 2010 Feb; 43: 246-252
59. Nemeth I, Boda D. Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome. Intensive Care Med 2001; 27: 216-221
60. Reichenbach J, Schubert R, Schindler D, Muller K, Bohles H, Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal 2002; 4: 465-469
61. Ross BM, McKenzie I, Glen I, Bennett CP Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 2003; 6: 277-281
62. Sogut S, Zoroglu SS, Ozyurt H, Yilmaz HR, Ozugurlu F Sivasli E, et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 2003; 331: 111-117
63. James SJ, Cutler P Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80: 1611-1617
64. Ming X, Stein TP Brimacombe M, Johnson WG, Lambert GH, Wagner GC. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 379-384
65. Kolker S, Mayatepek E, Hoffmann GF White matter disease in cerebral organic acid disorders: clinical implications and suggested pathomechanisms. Neuropediatrics 2002; 33: 225-231
66. Kulak W, Sobaniec W, Solowej E, Sobaniec H. Anti - oxidant enzymes and lipid peroxides in children with cerebral palsy. Life Sci 2005; 77: 3031-3036
67. Yamamoto T, Shibata N, Kobayashi M, Saito K, Osawa M. Oxidative stress in the brain of Fukuyama type congenital muscular dystrophy: immunohisto- chemical study on astrocytes. J Child Neurol 2002; 17: 793-799
68. Rodriguez MC, Tarnopolsky MA. Patients with dystro- phinopathy show evidence of increased oxidative stress. Free Radic Biol Med 2003; 34: 1217-1220
69. Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neuro I ogy 2003; 60: 993-997
70. Gupta M, Gupta YK, Agarwal S, Aneja S, Kalaivani M, Kohli K. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsia 2004; 45: 1636-1639
71. Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace elements, electrolytes, and oxidative stress/ antioxidant systems in epileptic patients. J Pharmacol Sci 2004; 96: 465-473
72. Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, et al. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch Neurol 2005; 62: 621-626
73. Chariot P, Bignani O. Skeletal muscle disorders associated with selenium deficiency in humans. Muscle Nerve 2003; 27: 662-668
74. Hayashi M, Araki S, Arai N, Kumada S, Itoh M, Tamagawa K, et al. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy. Brain Dev 2002; 24: 770-775
75. Bayir H, Kagan VE, Tyurina YY, Tyurin V, Ruppel RA, Adelson PD, et al. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res 2002; 51: 571-578
76. Bayir H, Kochanek PM, Clark RS. Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit. Crit Care Clin 2003; 19: 529-549
77. Bockowski L, Sobaniec W, Kutak W, Smigielska-Kuzia J. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 2008; 60: 542-548
78. Pavlova EL, Lilova MI, Savov VM. Oxidative stress in children with kidney disease. Pediatr Nephrol 2005; 20: 1599-1604
79. Zwolinska D, Grzeszczak W, Szczepanska M, Kilis- Pstrusinska K, Szprynger K. Vitamins A, E and C as non-enzymatic antioxidants and their relation to lipid peroxidation in children with chronic renal failure. Nephron Clin Pract 2006; 103: c12-c18.
80. Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El- Saaid GS, Ismail AA. Oxidative stress markers and C- reactive protein in pediatric patients on hemodialysis. Ann Nutr Metab 2009; 55: 309-316
81. Starosta V, Griese M. Protein oxidation by chronic pulmonary diseases in children. Pediatr Pulmonol 2006; 41: 67-73. (Pubitemid 43117370)
82. Back EI, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr 2004; 80:374-384
83. Kettle AJ, Chan T, Osberg I, Senthilmohan R, Chapman AL, Mocatta TJ, Wagener JS. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004; 170:1317-1323
84. Omata N, Tsukahara H, Ito S, Ohshima Y, Yasutomi M, Yamada A, et al. Increased oxidative stress in childhood atopic dermatitis. Life Sci 2001; 69: 223-228
85. Tsukahara H, Shibata R, Ohshima Y, Todoroki Y, Sato S, Ohta N, et al. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci 2003; 72: 2509-2516
86. Corradi M, Folesani G, Andreoli R, Manini P, Bodini A, Piacentini G, et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003; 167: 395-399 (Pubitemid 36216422)
87. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003; 35: 213-225
88. Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI, Del Rio-Navarro BE, Ruiz-Navarro MX, et al. Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone. Clin Exp Immunol 2004; 138:317-322
89. Renke J, Popadiuk S, Korzon M, Bugajczyk B, Wozniak M. Protein carbonyl groups' content as a useful clinical marker of antioxidant barrier impairment in plasma of children with juvenile chronic arthritis. Free Radic Biol Med 2000; 29: 101-104
90. Lotito AP, Muscara MN, Kiss MH, Teixeira SA, Novaes GS, Laurindo IM, et al. Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. J Rheumatol 2004; 31: 992-997
91. Erdogan O, Oner A, Aydin A, Isimer A, Demircin G, Bulbul M. Effect of vitamin E treatment on the oxi - dative damage occurring in Henoch-Schonlein purpura. Acta Paediatr 2003; 92: 546-550
92. Posadas-Romero C, Torres-Tamayo M, Zamora- Gonzalez J, Aguilar-Herrera BE, Posadas-Sanchez R, Cardoso-Saldana G, et al. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum 2004; 50: 160-165
93. Dordević VB, Stanković T, Ćosić V, Zvezdanović L, Kamenov B, Tasić-Dimov D, Stojanović I. Immune system-mediated endothelial damage is associated with NO and antioxidant system disorders. Clin Chem Lab Med 2004; 42: 1117-1121
94. Tuo J, Jaruga P, Rodriguez H, Bohr VA, Dizdaroglu M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEBJ 2003; 17:668-674
95. Gualandri W, Gualandri L, Demartini G, Esposti R, Marthyn P Volonte S, et al. Redox balance in patients with Down's syndrome before and after dietary supplementation with alpha-lipoic acid and L-cysteine. Int J Clin Pharmacol Res 2003; 23: 23-30.
96. Pastore A, Tozzi G, Gaeta LM, Giannotti A, Bertini E, Federici G, et al. Glutathione metabolism and antioxidant enzymes in children with Down syndrome. J Pediatr 2003; 142: 583-585
97. Surdacki A, Tsikas D, Mayatepek E, Frolich JC. Elevated urinary excretion of nitric oxide metabolites in young infants with Zellweger syndrome. Clin Chim Acta 2003; 334: 111-115
98. Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004; 17: 1063-1068
99. Mohn A, Catino M, Capanna R, Giannini C, Marco- vecchio M, Chiarelli F Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. J Clin Endocrinol Metab 2005; 90: 2653-2658
100. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003; 108: 1059-1063
101. Manary MJ, Leeuwenburgh C, Heinecke JW. Increased oxidative stress in kwashiorkor. J Pediatr 2000; 137:421-424
102. Becker K, Pons-Kuhnemann J, Fechner A, Funk M, Gromer S, Gross HJ, et al. Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor - a pilot study. Redox Rep 2005; 10: 215-226
103. Denicola A, Radi R. Peroxynitrite and drug-dependent toxicity. Toxicology 2005; 208: 273-288
104. Conklin KA. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther 2005; 4: 110-130
105. Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J, Kelly KM. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer 2005; 44: 378-385
106. Simbre VC, Duffy SA, Dadlani GH, Miller TL, Lipshultz SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs 2005; 7: 187-202.
107. Stolarska M, Mlynarski W, Zalewska-Szewczyk B, Bodalski J. Cytoprotective effect of amifostine in the treatment of childhood neoplastic diseases - a clinical study including the pharmacoeconomic analysis. Pharmacol Rep 2006; 58: 30-34
108. Parra Cid T, Conejo Garcia JR, Carballo Alvarez F, De Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003; 189: 99-111.
109. Facorro G, Sarrasague MM, Torti H, Hager A, Avalos JS, Foncuberta M, Kusminsky G. Oxidative study of patients with total body irradiation: effects of amifostine treatment. Bone Marrow Transplant 2004; 33: 793-798
110. Wong RH, Kuo CY, Hsu ML, Wang TY, Chang PI, Wu TH, Huang S. Increased levels of 8-hydroxy-2′- deoxyguanosine attributable to carcinogenic metal exposure among schoolchildren. Environ. Health Perspect 2005; 113: 1386-1390
111. Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 2005; 100: 61-64 (Pubitemid 40487937)
112. Tondel M, Arynchyn A, Jonsson P Persson B, Tagesson C. Urinary 8-hydroxydeoxyguanosine in Belarussian children relates to urban living rather than radiation dose after the Chernobyl accident: a pilot study. Arch Environ Contam Toxicol 2005; 48: 515-519
113. Nikolić-Kokić A, Blagojević D, Spasić BM. Complexity of free radical metabolism in human erythrocytes. Journal of Medical Biochemistry 2010; 29: 189-195.
114. Harinarayanan S, James R, Rao A. Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 2002; 325:147-150
115. Nagano T, Yoshimura T. Bioimaging of nitric oxide. Chem Rev 2002; 102: 1235-1270
116. Noiri E, Tsukahara H. Parameters for measurement of oxidative stress in diabetes mellitus: applicability of enzyme-linked immunosorbent assay for clinical evaluation. J Investig Med 2005; 53: 167-175
117. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999; 9: 109-113
118. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gast Nutr 1998; 26: 85-89
119. Portal B, Richard MJ, Coudray C, Arnaud J, Favier A. Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in cystic fibrosis patients. Clin Chim Acta 1995; 234: 137-146
120. Bean JP Sy A. Vitamin E supplementation in Senegalese children with kwashirorkor. Sante 1996; 6: 209-212
121. Mailila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and betacarotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999; 8: 489-493
122. Wang XD, Russell RM. Procarcinogenic and anticar- cinogenic effects of beta carotene. Nutr Rev 1999; 57: 263-272
123. Kojic S. MARP protein family: A possible role in molecular mechanisms of tumorigenesis. Journal of Medical Biochemistry 2010; 29: 157-164.
124. Krinsky NI, Beecher GR, Burk RF, Chan AC, Erdman JW, Jacob RA. Panel on Dietary Antioxidants and Related Compounds. Food and Nutrition Board, National Academy of Sciences, National Academy Press, 2000.